Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics.

Naderyan Fe'li, Shadi; Yassini Ardekani, Seyed Mojtaba; Fallahzadeh, Hosein; Dehghani, Ali

Naderyan Fe'li, Shadi; Yassini Ardekani, Seyed Mojtaba; Fallahzadeh, Hosein; Dehghani, Ali.

Afiliación

Naderyan Fe'li S; Department of Biostatistics and Epidemiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Yassini Ardekani SM; Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Fallahzadeh H; Department of Biostatistics and Epidemiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Dehghani A; Department of Biostatistics and Epidemiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Med J Islam Repub Iran ; 33: 97, 2019.

Article en En | MEDLINE | ID: mdl-31696091

Palabras clave

Antipsychotic; Cardiovascular disease; Metabolic syndrome; Schizophrenia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Med J Islam Repub Iran Año: 2019 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google